Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib and Docetaxel in HRPC
NCT00795171Phase 2Unknown
- Sponsor
- Medical University of Vienna
- Start
- Nov 2008
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in prostate cancer (PCa), sponsored by Medical University of Vienna. Status: unknown.
02
Drugs
sunitinib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00795171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00795171.